Publication:
The relationship between venous insufficiency and serum magnesium level

dc.contributor.authorÇalışkan, Serhat
dc.contributor.authorAtay, Mehmet
dc.contributor.buuauthorGÜNAY POLATKAN, ŞEYDA
dc.contributor.buuauthorSığırlı, Deniz
dc.contributor.buuauthorSIĞIRLI, DENİZ
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı.
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Biyoistatistik Anabilim Dalı.
dc.contributor.researcheridGNH-5913-2022
dc.date.accessioned2024-10-31T11:24:36Z
dc.date.available2024-10-31T11:24:36Z
dc.date.issued2022-10-01
dc.description.abstractBackground: Magnesium is the second most common cation in the cell. In addition to its role as a cofactor in many enzymatic pathways in physiological processes, it is necessary for the regular functioning of vascular smooth muscle cells. Magnesium deficiency has been associated with exacerbation of inflammation, which plays a role in the aetiopathogenesis of many diseases. Aim: To investigate the potential relationship between serum magnesium level and the development of chronic venous insufficiency by comparison with healthy individuals. Methods: The study included 394 patients with venous insufficiency based on physical examination findings and colour Doppler ultrasonography, and 206 controls without venous insufficiency. Venous insufficiency was defined by colour Doppler as reflux lasting 0.5 seconds or more in superficial veins, and longer than one second in femoral and popliteal veins. Clinical, haematological and biochemical parameters, including serum magnesium level and indicators of inflammation, were compared between groups. Results: A total of 600 participants were included. There was no significant difference between the groups in terms of age and gender. In total, 187 (47.46%) patients with chronic venous insufficiency and 105 (50.97%) of the control group were male (p=0.414). The median age of the patients with chronic venous insufficiency was 48 (min-max: 41-49), and the median age of the control group was 49.00 (min-max: 45.00-60.25) (p=0.064). Serum magnesium level was found to be significantly lower in the group with chronic venous insufficiency compared to the control group; 1.90 mg/dL (min-max: 1.82-2) versus 2.1 mg/dL (min-max: 2-2.2) (p<0.001), respectively. Conclusion: Low serum magnesium levels may pose a potential risk for the development of chronic venous insufficiency, which is common in the community.
dc.identifier.doi10.1684/mrh.2023.0508
dc.identifier.endpage117
dc.identifier.issn0953-1424
dc.identifier.issue4
dc.identifier.startpage108
dc.identifier.urihttps://doi.org/10.1684/mrh.2023.0508
dc.identifier.urihttps://hdl.handle.net/11452/47255
dc.identifier.volume35
dc.identifier.wos000973058600001
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherJohn Libbey Eurotext Ltd
dc.relation.journalMagnesium Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectC-reactive protein
dc.subjectTo-lymphocyte ratio
dc.subjectSmooth-muscle-cells
dc.subjectEndothelial dysfunction
dc.subjectMyocardial-infarction
dc.subjectCholesterol ratio
dc.subjectCoronary flow
dc.subjectNeutrophil
dc.subjectPlatelet
dc.subjectDisease
dc.subjectVenous insufficiency
dc.subjectInflammation
dc.subjectMagnesium
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectBiochemistry & molecular biology
dc.subjectEndocrinology & metabolism
dc.titleThe relationship between venous insufficiency and serum magnesium level
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication2fce7938-9be9-404c-b4d0-3798583496b8
relation.isAuthorOfPublicationf8b7b771-12ea-4f9a-889d-25079d8c862d
relation.isAuthorOfPublication.latestForDiscovery2fce7938-9be9-404c-b4d0-3798583496b8

Files

Collections